CN110446502B - 用于联合非混合使用的含猪病原体的疫苗 - Google Patents

用于联合非混合使用的含猪病原体的疫苗 Download PDF

Info

Publication number
CN110446502B
CN110446502B CN201880022778.9A CN201880022778A CN110446502B CN 110446502 B CN110446502 B CN 110446502B CN 201880022778 A CN201880022778 A CN 201880022778A CN 110446502 B CN110446502 B CN 110446502B
Authority
CN
China
Prior art keywords
vaccine
prrs
pcv
immunogen
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880022778.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN110446502A (zh
Inventor
M.H.维特夫利特
E.范登博恩
M.斯诺
A.A.C.雅各布斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN110446502A publication Critical patent/CN110446502A/zh
Application granted granted Critical
Publication of CN110446502B publication Critical patent/CN110446502B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201880022778.9A 2017-04-13 2018-04-12 用于联合非混合使用的含猪病原体的疫苗 Active CN110446502B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17166590 2017-04-13
EP17166590.4 2017-04-13
PCT/EP2018/059389 WO2018189290A1 (en) 2017-04-13 2018-04-12 Vaccines containing swine pathogens for associated non-mixed use

Publications (2)

Publication Number Publication Date
CN110446502A CN110446502A (zh) 2019-11-12
CN110446502B true CN110446502B (zh) 2024-01-26

Family

ID=58547447

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880022778.9A Active CN110446502B (zh) 2017-04-13 2018-04-12 用于联合非混合使用的含猪病原体的疫苗

Country Status (9)

Country Link
US (1) US11311614B2 (https=)
EP (2) EP3609533A1 (https=)
JP (2) JP7665289B2 (https=)
KR (1) KR102724420B1 (https=)
CN (1) CN110446502B (https=)
CA (1) CA3058281A1 (https=)
MX (1) MX390682B (https=)
RU (1) RU2756767C2 (https=)
WO (1) WO2018189290A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11311614B2 (en) * 2017-04-13 2022-04-26 Intervet Inc. Vaccines containing swine pathogens for associated non-mixed use
CA3176154A1 (en) 2020-04-20 2021-10-28 Maarten Hendrik Witvliet A combination of vaccines to prophylactically treat a pig

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102006884A (zh) * 2008-04-18 2011-04-06 英特威国际有限公司 防御胞内劳森菌、猪肺炎支原体和猪圆环病毒的疫苗

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
CA2423588A1 (en) * 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Improved vaccines for proliferative ileitis and methods of making and using the same
KR20070096019A (ko) 2005-01-13 2007-10-01 베링거잉겔하임베트메디카게엠베하 향상된 ｐｒｒｓ 백신
KR101347503B1 (ko) 2005-09-09 2014-01-02 인터벳 인터내셔널 비.브이. Ｐｃｖ-2 백신
MX338626B (es) 2005-12-29 2016-04-26 Boehringer Ingelheim Vetmed Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
JP5200223B2 (ja) 2006-12-15 2013-06-05 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド Ｐｃｖ２抗原によるブタの処置
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
EP3076997B1 (en) 2013-12-03 2018-08-29 Intervet International B.V. Swine vaccine against prrs and lawsonia intracellularis
JP6488304B2 (ja) 2013-12-03 2019-03-20 インターベット インターナショナル ベー． フェー． ローソニア・イントラセルラリス（ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）及びブタサーコウイルス（ｐｏｒｃｉｎｅ ｃｉｒｃｏｖｉｒｕｓ）２に対するワクチン
ES2771899T3 (es) * 2013-12-03 2020-07-07 Intervet Int Bv Vacuna contra circovirus porcino de tipo 2
US20200023128A1 (en) * 2016-12-22 2020-01-23 Intervet Inc. Needleless injector
US11311614B2 (en) * 2017-04-13 2022-04-26 Intervet Inc. Vaccines containing swine pathogens for associated non-mixed use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102006884A (zh) * 2008-04-18 2011-04-06 英特威国际有限公司 防御胞内劳森菌、猪肺炎支原体和猪圆环病毒的疫苗

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Field efficacy study of a novel ready-to-use vaccine against mycoplasma hyopneumoniae and porcine circovirus type 2 in a Greek farm;Eleni D Tzika等;《Porcine Health Manag .》;第1卷(第1期);15 *
Performance of weaned pigs vaccinated with 3FLEX™ compared to pigs vaccinated with Ingelvac® CircoFLEX-MycoFLEX™and Ingelvac® PRRS MLV in separate injections;S Blood等;《 Allen D. Leman Swine Conference》;第263页左栏第2段 *
S Blood等.Performance of weaned pigs vaccinated with 3FLEX™ compared to pigs vaccinated with Ingelvac® CircoFLEX-MycoFLEX™and Ingelvac® PRRS MLV in separate injections.《 Allen D. Leman Swine Conference》.2011,第263页左栏第2段. *

Also Published As

Publication number Publication date
US20200046825A1 (en) 2020-02-13
JP2020513027A (ja) 2020-04-30
RU2756767C2 (ru) 2021-10-05
EP3609533A1 (en) 2020-02-19
JP7665289B2 (ja) 2025-04-21
KR20190134650A (ko) 2019-12-04
MX390682B (es) 2025-03-21
CA3058281A1 (en) 2018-10-18
MX2019012220A (es) 2019-12-09
JP2023025210A (ja) 2023-02-21
KR102724420B1 (ko) 2024-10-30
WO2018189290A1 (en) 2018-10-18
RU2019136252A (ru) 2021-05-13
CN110446502A (zh) 2019-11-12
EP4335455A3 (en) 2024-05-22
US11311614B2 (en) 2022-04-26
RU2019136252A3 (https=) 2021-05-13
EP4335455A2 (en) 2024-03-13

Similar Documents

Publication Publication Date Title
US20090317423A1 (en) Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
JP6907227B2 (ja) Ｐｃｖ２ウイルス及びマイコプラズマ・ハイオニューモニエ感染症に対する混合ワクチン
TW201828982A (zh) 抗豬小病毒及豬生殖與呼吸道症候群病毒之疫苗及其製造方法
WO2008121958A1 (en) Use of prrsv vaccines to reduce pcv2 viremia
CN105579060A (zh) Pcv2b趋异株疫苗组合物以及使用方法
JP2023025210A (ja) 組合せ非混合使用のためのブタ病原体含有ワクチン
US12594328B2 (en) Combination of vaccines to prophylactically treat a pig
US11654191B2 (en) Vaccine for intradermal application against PCV2 and PRRS virus infection
RU2834834C1 (ru) Комбинация вакцин для профилактического лечения свиней
KR101549744B1 (ko) 돼지 써코바이러스 2형 및 돼지 마이코플라즈마성 폐렴 예방을 위한 혼합백신 조성물
US10953084B2 (en) Combination vaccine against PCV2 and PRRS virus infection comprising albumin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant